Skip to main content

Advertisement

Log in

Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have been described worldwide, but there are few reports on the carriage of these bacteria in Cameroon. In order to investigate the types of ESBLs and to analyse some risk factors associated with ESBL carriage, faecal samples were collected between 3 January and 3 April 2009 from hospitalised patients at Yaounde Central Hospital and at two hospitals in Ngaoundere, Cameroon. Enterobacterial isolates resistant to third-generation cephalosporins were screened for ESBL production using the double-disk synergy test. Polymerase chain reaction (PCR) and DNA sequencing were performed in order to find out the different types of ESBL genes in presumptive ESBL-positive isolates. During the study period, a total of 121 different patients were screened for ESBL carriage. The prevalence among these patients whose faecal samples were found to contain ESBL-producers was 55.3 % (67/121). According to a univariate analysis, hospitalisation during the previous year was found to be associated with ESBL carriage. Of the 71 bacteria isolated, Escherichia coli was predominant and represented 48 % of all isolates. ESBL characterisation revealed two types of ESBLs, CTX-M-15 (96 %) and SHV-12 (4 %). The present study emphasises the importance of screening for ESBLs in laboratories in African countries. The monitoring and detection of ESBL-producing bacteria are important in the setting up of appropriate treatment of patients and to ensure effective infection control efforts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Song W, Kim J, Bae IK, Jeong SH, Seo YH, Shin JH, Jang SJ, Uh Y, Shin JH, Lee MK, Lee K (2011) Chromosome-encoded AmpC and CTX-M extended-spectrum beta-lactamases in clinical isolates of Proteus mirabilis from Korea. Antimicrob Agents Chemother 55(4):1414–1419

    Article  PubMed  CAS  Google Scholar 

  2. Fabre L, Delaune A, Espie E, Nygard K, Pardos M, Polomack L, Guesnier F, Galimand M, Lassen J, Weill FX (2009) Chromosomal integration of the extended-spectrum beta-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children. Antimicrob Agents Chemother 53(5):1808–1816

    Article  PubMed  CAS  Google Scholar 

  3. Cantón R, González-Alba JM, Galán JC (2012) CTX-M enzymes: origin and diffusion. Front Microbiol 3:110

    PubMed  Google Scholar 

  4. Rahal JJ (2000) Extended-spectrum beta-lactamases: how big is the problem? Clin Microbiol Infect 6(Suppl 2):2–6

    Article  PubMed  CAS  Google Scholar 

  5. Colodner R, Raz R (2005) Extended-spectrum beta-lactamases: the end of cephalosporins? Isr Med Assoc J 7(5):336–338

    PubMed  Google Scholar 

  6. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11(6):315–317

    Article  PubMed  CAS  Google Scholar 

  7. Breurec S, Guessennd N, Timinouni M, Le TA, Cao V, Ngandjio A, Randrianirina F, Thiberge JM, Kinana A, Dufougeray A, Perrier-Gros-Claude JD, Boisier P, Garin B, Brisse S (2012) Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect. [Epub ahead of print]

  8. Gangoué-Piéboji J (2007) Caractérisation des beta-lactamases et leur inhibition par les extraits de plantes médicinales. BICTEL/e—ULG Serveur institutionnel des thèses de doctorat

  9. Gangoué-Piéboji J, Bedenic B, Koulla-Shiro S, Randegger C, Adiogo D, Ngassam P, Ndumbe P, Hächler H (2005) Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 43(7):3273–3277

    Article  PubMed  Google Scholar 

  10. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10(4):867–878

    Article  PubMed  CAS  Google Scholar 

  11. Clinical and Laboratory Standards Institute (CLSI) (2010) Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20. CLSI, Wayne, PA

  12. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65(3):490–495

    Article  PubMed  CAS  Google Scholar 

  13. Pagani L, Dell’Amico E, Migliavacca R, D’Andrea MM, Giacobone E, Amicosante G, Romero E, Rossolini GM (2003) Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J Clin Microbiol 41(9):4264–4269

    Article  PubMed  CAS  Google Scholar 

  14. Bomasang ES, Mendoza MT (2003) Prevalence and risk factors associated with extended spectrum beta lactamase (ESBL) production among selected Enterobacteriaceae isolates at the Philippine General Hospital. Phil J Microbiol Infect Dis 32:151–158

    Google Scholar 

  15. Tonkic M, Goic-Barisic I, Punda-Polic V (2005) Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol 8(2):119–124

    PubMed  CAS  Google Scholar 

  16. Ramazanzadeh R, Mansouri M (2009) Spread of extended-spectrum beta-lactamase producing Escherichia coli clinical isolates in Sanandaj hospitals. J Biol Sci 9:362–366

    Article  Google Scholar 

  17. Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370–1374

    Article  PubMed  CAS  Google Scholar 

  18. Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH; Study Group ‘Antimicrobial Resistance in Indonesia: Prevalence and Prevention’ (AMRIN) (2010) Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 65(3):465–469

    Article  PubMed  CAS  Google Scholar 

  19. Ahoyo AT, Baba-Moussa L, Anago AE, Avogbe P, Missihoun TD, Loko F, Prévost G, Sanni A, Dramane K (2007) Incidence of infections dues to Escherichia coli strains producing extended spectrum betalactamase, in the Zou/Collines Hospital Centre (CHDZ/C) in Benin. Med Mal Infect 37(11):746–752

    Article  PubMed  CAS  Google Scholar 

  20. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N (2005) High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43(2):745–749

    Article  PubMed  Google Scholar 

  21. Seid J, Asrat D (2005) Occurrence of extended spectrum beta-lactamase enzymes in clinical isolates of Klebsiella species from Harar region, eastern Ethiopia. Acta Trop 95(2):143–148

    Article  PubMed  CAS  Google Scholar 

  22. Mirelis B, Navarro F, Miró E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9(8):1024–1025

    Article  PubMed  Google Scholar 

  23. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA (2004) Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 101(10):3709–3714

    Article  PubMed  CAS  Google Scholar 

  24. Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Okomo Assoumou MC, Melin P, De Mol P (2012) Proportion of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 12(1):53

    Article  PubMed  Google Scholar 

  25. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163–167

    Article  PubMed  CAS  Google Scholar 

  26. Andriatahina T, Randrianirina F, Hariniana ER, Talarmin A, Raobijaona H, Buisson Y, Richard V (2010) High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect Dis 10:204

    Article  PubMed  Google Scholar 

  27. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 57(4):780–783

    Article  PubMed  CAS  Google Scholar 

  28. Rodríguez-Baño J, Navarro MD, Romero L, Martínez-Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089–1094

    Article  PubMed  Google Scholar 

  29. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32(8):1162–1171

    Article  PubMed  CAS  Google Scholar 

  30. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B, Weber R (2010) Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 38(1):33–40

    Article  PubMed  CAS  Google Scholar 

  31. Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine MH (2011) CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 17(1):67–73

    Article  PubMed  CAS  Google Scholar 

  32. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42(7):925–934

    Article  PubMed  CAS  Google Scholar 

  33. Gangoué-Piéboji J, Koulla-Shiro S, Ngassam P, Adiogo D, Ndumbe P (2006) Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon. Afr Health Sci 6(4):232–235

    PubMed  Google Scholar 

  34. Peirano G, van Greune CH, Pitout JD (2011) Characteristics of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn Microbiol Infect Dis 69(4):449–453

    Article  PubMed  CAS  Google Scholar 

  35. Drieux L, Brossier F, Duquesnoy O, Aubry A, Robert J, Sougakoff W, Lecso-Bornet M, Jarlier V (2009) Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital. Eur J Clin Microbiol Infect Dis 28(5):491–498

    Article  PubMed  CAS  Google Scholar 

  36. Silva J, Aguilar C, Becerra Z, López-Antuñano F, García R (1999) Extended-spectrum beta-lactamases in clinical isolates of enterobacteria in Mexico. Microb Drug Resist 5(3):189–193

    Article  PubMed  CAS  Google Scholar 

  37. Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, Yip KS, Lai EL, Tsang KW; COMBAT study group (2007) Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60(1):140–144

    Article  PubMed  CAS  Google Scholar 

  38. Ndugulile F, Jureen R, Harthug S, Urassa W, Langeland N (2005) Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC Infect Dis 5:86

    Article  PubMed  Google Scholar 

  39. Ehlers MM, Veldsman C, Makgotlho EP, Dove MG, Hoosen AA, Kock MM (2009) Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital. FEMS Immunol Med Microbiol 56(3):191–196

    Article  PubMed  CAS  Google Scholar 

  40. Touati A, Brasme L, Benallaoua S, Madoux J, Gharout A, de Champs C (2008) Enterobacter cloacae and Klebsiella pneumoniae isolates producing CTX-M-15 recovered from hospital environmental surfaces from Algeria. J Hosp Infect 68(2):183–185

    Article  PubMed  CAS  Google Scholar 

  41. Touati A, Benallaoua S, Forte D, Madoux J, Brasme L, de Champs C (2006) First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria. Int J Antimicrob Agents 27(5):397–402

    Article  PubMed  CAS  Google Scholar 

  42. Touati A, Benallaoua S, Djoudi F, Madoux J, Brasme L, De Champs C (2007) Characterization of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from hospital environments in Algeria. Microb Drug Resist 13(2):85–89

    Article  PubMed  CAS  Google Scholar 

  43. Olowe OA, Grobbel M, Büchter B, Lübke-Becker A, Fruth A, Wieler LH (2010) Detection of bla(CTX-M-15) extended-spectrum beta-lactamase genes in Escherichia coli from hospital patients in Nigeria. Int J Antimicrob Agents 35(2):206–207

    Article  PubMed  CAS  Google Scholar 

  44. Frank T, Arlet G, Gautier V, Talarmin A, Bercion R (2006) Extended-spectrum beta-lactamase-producing Enterobacteriaceae, Central African Republic. Emerg Infect Dis 12(5):863–865

    Article  PubMed  Google Scholar 

  45. Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallègue O, Arlet G (2010) Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 16(2):163–170

    Article  PubMed  CAS  Google Scholar 

  46. Damjanova I, Tóth A, Pászti J, Bauernfeind A, Füzi M (2006) Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary. Eur J Clin Microbiol Infect Dis 25(4):275–278

    Article  PubMed  CAS  Google Scholar 

  47. Valenzuela de Silva EM, Mantilla Anaya JR, Reguero Reza MT, González Mejía EB, Pulido Manrique IY, Darío Llerena I, Velandia D (2006) Detection of CTX-M-1, CTX-M-15, and CTX-M-2 in clinical isolates of Enterobacteriaceae in Bogota, Colombia. J Clin Microbiol 44(5):1919–1920

    Article  PubMed  CAS  Google Scholar 

  48. Duval V, Maiga I, Maiga A, Guillard T, Brasme L, Forte D, Madoux J, Vernet-Garnier V, De Champs C (2009) High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali. Antimicrob Agents Chemother 53(11):4957–4958

    Article  PubMed  CAS  Google Scholar 

  49. Ramdani-Bouguessa N, Mendonça N, Leitão J, Ferreira E, Tazir M, Caniça M (2006) CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J Clin Microbiol 44(12):4584–4586

    Article  PubMed  CAS  Google Scholar 

  50. Gangoué-Piéboji J, Miriagou V, Vourli S, Tzelepi E, Ngassam P, Tzouvelekis LS (2005) Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrob Agents Chemother 49(1):441–443

    Article  PubMed  Google Scholar 

  51. Kariuki S, Corkill JE, Revathi G, Musoke R, Hart CA (2001) Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother 45(7):2141–2143

    Article  PubMed  CAS  Google Scholar 

  52. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I (2006) First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 27(6):545–548

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was performed at Yaounde Central Hospital, Ngaoundere Protestant Hospital and Ngaoundere Regional Hospital in Cameroon. We thank the authorities of these institutions for enabling us to conduct this study. We are grateful to the Chief Doctor, Simon Z. Aroga, who contributed to the study. We sincerely thank Moїse Woachie and all the laboratory technicians for their help in the collection of samples and in the interviews with the patients.

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. M. Lonchel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lonchel, C.M., Melin, P., Gangoué-Piéboji, J. et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals. Eur J Clin Microbiol Infect Dis 32, 79–87 (2013). https://doi.org/10.1007/s10096-012-1717-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-012-1717-4

Keywords

Navigation